The Zamasa Foundation’s constitution is based on the model provided by the NSW Office of Fair Trading. The Foundation is governed by its Board, which is supported by its Medical Advisory Panel.
Charity Name: The ZAMASA Foundation Incorporated
ASIC Registration: Registered as Registrable Australian Body (No. 624 269 218)
NSW Fair Trading: Registration Number – INC1800038
Date of Incorporation – 12 January 2018
Australian Charites and Not-for-Profits Commission: Registered on 7 February 2018 as a charity advancing health and as an institution whose principal activity is to promote the prevention and control of diseases in human beings.
Charitable Fundraising Number CFN/25160
Financial Year End: 30 June
Charitable / Deductibility Status: The ZAMASA Foundation is a Deductible Gift Recipient
The founding members of the committee are detailed below
B.Com(Hons) University of Melbourne (1990) / MA Economics (Distinction) University of London (1994)
Greg, together with the other five founding members, founded the ZAMASA Foundation in 2018. Greg is a principal of Ironstone Capital which he co-founded with three colleagues in 2011 and specialises in providing advisory services in mining, infrastructure, energy industries and to Commonwealth and State governments. Prior to Ironstone, Greg worked at various investment banks including Merrill Lynch, Chase Manhattan and the Royal Bank of Scotland in London and Sydney. Greg is a board member of The Arrow Bone Marrow Transplant Foundation
B.Com University of Sydney 1997
Post Grad. Dip Financial Planning (FINSIA)
Julia is an adviser with BW Capital, a boutique advisory firm whose clients are HNW individuals, family groups and NFP institutions. BW Capital has its foundations in Andersen’s tax division, where Julia was part of the team that established Andersen’s wealth management advisory business in Australia.
B.Com (Cum Laude) (1991) / Post Grad. Dip. Acc (1992) University of Natal
Graeme is currently Chief Financial Officer for Greenstone Pty Ltd which is a large distributor of direct insurance in Australia. Graeme’s previous roles have included Managing Director of an ASX listed entity and 14 years in Investment Banking with Credit Suisse and ABN Amro in London and Hong Kong.
B.Eng (Hons) University of New South Wales
Nick is a Mining Engineer with over 15 years’ experience in the resources sector in both site-based technical roles and working for financial institutions. Nick has experience as a debt and equity investor in the mining and resources sector working with a global investment bank in London and a specialist global natural resources private equity fund in Sydney.
B.Com University of Melbourne (1990) MBA, Melbourne Business School (1994) GAICD
Adam is a director at Ironstone Capital Advisory. Prior to Ironstone Adam worked at Royal Bank of Scotland for 10 years specialising in project finance and public private partnerships. Adam has also worked UBS Warburg, SG Australia and advised Infrastructure Australia. Adam is currently a member of the St Catherine’s School campaign committee raising funds for a major campus redevelopment.
B.Mining Eng UNSW (Broken Hill)
Paul is a founding director of the Pybar Group and Pybar Mining Services, one of Australia’s largest and most successful underground mining companies. Paul is a mining engineer with over 40 years’ experience in underground mine design, planning, mine management, production and development.
Conjoint Associate Professor
Dr John Moore graduated from Sydney University in 1989 and completed his residency and Haematology Advanced training at Royal North Shore Hospital. He was awarded Fellowship of the College of Physicians and Pathologists in 1997. He continued his training at the Westmead Children’s Hospital and subsequently became the Bone Marrow Transplant Coordinator at the Royal Free Hospital, London from 1997-1998. He returned to Australia in 1998 and completed a Doctorate of Medicine at St. Vincent’s Hospital whilst researching the role of Haematopoietic Stem cell Transplantation for Severe Rheumatoid Arthritis. He is currently a Senior Staff Specialist in the Haematology Department at St. Vincent’s Hospital and a Visiting Medical Officer at St. Vincent’s Private Hospital. He was the Chair of the Bone Marrow Transplant Committee of the Australian Leukaemia and Lymphoma Group (ALLG) from 2004-2006. He has been a member of the Executive of the ALLG from 2002-2006, Secretary from 2002-2004 and on the Safety and Data Monitoring Board from 2002-2006. He has been on the Medical Advisory Committee of the Leukaemia Foundation from 2002-2004. Dr Moore has been involved in clinical trials for the past ten years and is presently a Chief Investigator at St. Vincent’s Hospital in numerous clinical trials. His research interests include thymic differentiation of haematopoietic stem cells and clinical studies of haematopoietic stem cell transplant. He is a conjoint Senior Lecturer in Medicine at the University of New South Wales.